[Recent advance in von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou
Jing
J
Li
Nan-yun
NY
Zhou
Xiao-jun
XJ
D018952:Antigens, CD34 / Q000378:metabolism; D002292:Carcinoma, Renal Cell / Q000378:metabolism / Q000473:pathology; D016543:Central Nervous System Neoplasms / Q000378:metabolism / Q000473:pathology / Q000601:surgery / Q000648:ultrastructure; D003937:Diagnosis, Differential; D004806:Ependymoma / Q000378:metabolism / Q000473:pathology; D066246:ErbB Receptors / Q000378:metabolism; D018325:Hemangioblastoma / Q000378:metabolism / Q000473:pathology / Q000601:surgery / Q000648:ultrastructure; D006801:Humans; D008577:Meningeal Neoplasms / Q000378:metabolism / Q000473:pathology; D008579:Meningioma / Q000378:metabolism / Q000473:pathology; D009154:Mutation; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D014746:Vimentin / Q000378:metabolism; D006623:von Hippel-Lindau Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000601:surgery
D018952:Antigens, CD34; D014746:Vimentin; C512478:EGFR protein, human; D066246:ErbB Receptors